Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Mercadante

Showing results (1-10 of 418) with videos related to

Pageof 42
Sort By:
Current Medical Research and Opinion|November 15, 2011
The use of high doses of OROS hydromorphone in an acute palliative care unitSebastiano Mercadante
Expert Opinion on Pharmacotherapy|March 20, 2012
Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patientsSebastiano Mercadante
Journal of Palliative Medicine|March 7, 2022
Response to Sarbey: Why Standard Drug Treatments for the "Death Rattle" Should Be Discontinued (DOI: 10.1089/jpm.2021.0568): Death Rattle in Dying PatientsSebastiano Mercadante
Internal and Emergency Medicine|September 25, 2010
Management of cancer painSebastiano Mercadante
The Oncologist|May 14, 2020
The Endless Question of Opioid Doses for Breakthrough PainSebastiano Mercadante
Journal of Pain and Symptom Management|October 28, 2018
Author's ResponseSebastiano Mercadante
Journal of Pain and Symptom Management|May 4, 2004
Opioid consumption in Italy: industry is not necessarily business--look at the effectsSebastiano Mercadante
Anesthesia and Analgesia|April 24, 2004
Epidural treatment in advanced cancer patientsSebastiano Mercadante
Palliative Medicine|November 16, 2004
Cancer pain management in childrenSebastiano Mercadante
Journal of Pain and Symptom Management|June 7, 2024
The Mistery of Ketamine: The Misleading Conclusion of a Randomized Controlled TrialSebastiano Mercadante
Pageof 42

Showing results (1-10 of 418) with videos related to

Sort By:
Pageof 42
Current Medical Research and Opinion|November 15, 2011
The use of high doses of OROS hydromorphone in an acute palliative care unitSebastiano Mercadante
Expert Opinion on Pharmacotherapy|March 20, 2012
Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patientsSebastiano Mercadante
Journal of Palliative Medicine|March 7, 2022
Response to Sarbey: Why Standard Drug Treatments for the "Death Rattle" Should Be Discontinued (DOI: 10.1089/jpm.2021.0568): Death Rattle in Dying PatientsSebastiano Mercadante
Internal and Emergency Medicine|September 25, 2010
Management of cancer painSebastiano Mercadante
The Oncologist|May 14, 2020
The Endless Question of Opioid Doses for Breakthrough PainSebastiano Mercadante
Journal of Pain and Symptom Management|October 28, 2018
Author's ResponseSebastiano Mercadante
Journal of Pain and Symptom Management|May 4, 2004
Opioid consumption in Italy: industry is not necessarily business--look at the effectsSebastiano Mercadante
Anesthesia and Analgesia|April 24, 2004
Epidural treatment in advanced cancer patientsSebastiano Mercadante
Palliative Medicine|November 16, 2004
Cancer pain management in childrenSebastiano Mercadante
Journal of Pain and Symptom Management|June 7, 2024
The Mistery of Ketamine: The Misleading Conclusion of a Randomized Controlled TrialSebastiano Mercadante
Pageof 42